Paul Bunn Selected Research

Paul Bunn Research Topics

8	Neoplasms (Cancer) 01/2020 - 04/2002
5	Lung Neoplasms (Lung Cancer) 01/2020 - 04/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 07/2004
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Hearing Loss (Hearing Impairment) 02/2014
1	Breast Neoplasms (Breast Cancer) 07/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2009
1	Melanoma (Melanoma, Malignant) 01/2009
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2006
1	Neutropenia 05/2006
1	Necrosis 08/2004
1	Thrombosis (Thrombus) 08/2004
1	Disease Progression 07/2004
1	Mesothelioma 07/2004

2	Cisplatin (Platino)FDA LinkGeneric 05/2006 - 07/2004
1	RNA (Ribonucleic Acid)IBA 01/2020
1	VaccinesIBA 01/2009
1	AntigensIBA 01/2009
1	Carboplatin (JM8)FDA LinkGeneric 05/2006
1	Docetaxel (Taxotere)FDA Link 05/2006
1	Pharmaceutical PreparationsIBA 05/2006
1	Etoposide (VP 16)FDA LinkGeneric 05/2006
1	Gefitinib (Iressa)FDA Link 08/2004
1	Tyrosine Kinase InhibitorsIBA 08/2004
1	Monoclonal AntibodiesIBA 08/2004
1	N-acetylcochinol-O-phosphateIBA 08/2004
1	von Willebrand FactorIBA 08/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2004
1	ErbB Receptors (EGF Receptor)IBA 08/2004
1	Pemetrexed (MTA)FDA Link 07/2004
1	Drug CombinationsIBA 07/2004
1	Cytotoxins (Cytolysins)IBA 07/2004
1	AntimetabolitesIBA 07/2004
1	Gemcitabine FDA Link 07/2004
1	CU201IBA 04/2002
1	Bradykinin Receptor AntagonistsIBA 04/2002
1	NeuropeptidesIBA 04/2002
1	Cell Surface ReceptorsIBA 04/2002
1	BradykininIBA 04/2002
1	Substance PIBA 04/2002